Duopharma inks product distribution agreement with SCM Lifescience

SCM Lifescience CEO Dr. Byong Kwan Son (left) and Duopharma group managing director Leonard Ariff Abdul Shatar (right).

KUALA LUMPUR: Duopharma Biotech Bhd’s wholly-owned subsidiary, Duopharma Consumer Healthcare Sdn Bhd has signed a product distribution agreement with South Korea-based stem cell technology company SCM Lifescience, Inc to distribute a range of IRORO brand halal-certified anti-hair loss products in Malaysia.

“This agreement with SCM Lifescience enables Duopharma Consumer Healthcare to expand our entry into the cosmeceutical segment with the halal-certified IRORO range specially formulated for Malaysia.

“Following Duopharma Biotech’s 2.73% investment into SCM Lifescience, we are committed to optimising their findings - particularly in stem cell research, to elevate our consumer product offerings, enabling us to have a unique advantage in the market,” group managing director Leonard Ariff Abdul Shatar said in a statement.

He disclosed that Duopharma was currently collaborating with SCM Lifescience to develop atopic dermatitis stem cell therapy.

“Through the introduction of the IRORO range, we are laying the groundwork for this product segment ahead of a potential launch of products to treat atopic dermatitis,” he added.